Actinogen:FDA同意仅需进行一项额外的关键试验,采用单一10毫克Xanamem剂量设计对比安慰剂的阿尔茨海默病试验

美股速递
Sep 15, 2025

Actinogen:FDA同意仅需进行一项额外的关键试验,采用单一10毫克Xanamem剂量设计对比安慰剂的阿尔茨海默病试验

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10